Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term T-cell type acute leukaemia
ADR ID BADD_A11012
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.01      Leukaemias acute lymphocytic
16.01.01.007      T-cell type acute leukaemia
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.01      Leukaemias acute lymphocytic
01.10.01.007      T-cell type acute leukaemia
11      Infections and infestations
11.05      Viral infectious disorders
11.05.17      Retroviral infections
11.05.17.013      T-cell type acute leukaemia
Description Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. [MeSH]
MedDRA Code 10042987
MeSH ID D015459
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
ATLL | T-cell type acute leukaemia | T-cell type acute leukemia | T-cell lymphoblastic leukaemia acute | T-cell lymphoblastic leukemia acute | Leukemia-Lymphoma, Adult T-Cell | Adult T-Cell Leukemia-Lymphoma | Adult T-Cell Leukemia-Lymphomas | Leukemia-Lymphomas, Adult T-Cell | T-Cell Leukemia-Lymphomas, Adult | HTLV I Associated T Cell Leukemia Lymphoma | HTLV-Associated Leukemia-Lymphoma | HTLV Associated Leukemia Lymphoma | HTLV-Associated Leukemia-Lymphomas | Leukemia-Lymphoma, HTLV-Associated | Leukemia-Lymphomas, HTLV-Associated | HTLV-I-Associated T-Cell Leukemia-Lymphoma | HTLV-I-Associated T-Cell Leukemia-Lymphomas | Leukemia-Lymphoma, HTLV-I-Associated T-Cell | Leukemia-Lymphomas, HTLV-I-Associated T-Cell | T-Cell Leukemia-Lymphomas, HTLV-I-Associated | Human T Lymphotropic Virus Associated Leukemia Lymphoma | Human T Lymphotropic Virus-Associated Leukemia-Lymphoma | Human T-Cell Leukemia-Lymphoma | Human T Cell Leukemia Lymphoma | Human T-Cell Leukemia-Lymphomas | Leukemia-Lymphoma, Human T-Cell | Leukemia-Lymphomas, Human T-Cell | T-Cell Leukemia-Lymphoma, Human | T-Cell Leukemia-Lymphomas, Human | Leukemia Lymphoma, Adult T Cell | Leukemia Lymphoma, T Cell, Acute, HTLV I Associated | Leukemia, Adult T-Cell | Adult T-Cell Leukemia | Adult T-Cell Leukemias | Leukemia, Adult T Cell | Leukemias, Adult T-Cell | T-Cell Leukemias, Adult | Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated | T Cell Leukemia Lymphoma, HTLV I Associated | T Cell Leukemia, Adult | T-Cell Leukemia, Adult | T-Cell Leukemia-Lymphoma, Adult | T Cell Leukemia Lymphoma, Adult | T-Cell Leukemia-Lymphoma, HTLV-I-Associated
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00931Fluorouracil0.000184%
BADD_D01549Nelarabine0.000168%
The 1th Page    1    Total 1 Pages